Baxter International | مصاريف البيع والإدارة



Selling And Administration Expenses تغيير تاريخ
Abbott USD 3.05B 144M 2025-03
AtriCure USD 76.05M 3.87M 2025-03
Avanos Medical USD 75.7M 3.9M 2025-03
Baxter International USD 703M 88M 2025-03
Becton, Dickinson and Co. USD 1.27B 45M 2025-03
Boston Scientific USD 1.6B 15M 2025-03
Cooper Companies USD 387.9M 3.5M 2025-01
Dexcom USD 310.1M 17.3M 2025-03
Edwards Lifesciences USD 465.7M 26.2M 2025-03
Fresenius EUR 643M 126M 2025-03
Globus Medical USD 242.8M 10.68M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
ICU Medical USD 157.23M 1.3M 2025-03
Insulet USD 260.6M 400K 2025-03
Integra LifeSciences USD 164M 5.61M 2025-03
Intuitive Surgical USD 563.4M 49.2M 2025-03
J&J USD 5.11B 1.34B 2025-03
Laboratory Of America USD 546M 49.2M 2025-03
Masimo USD 119.4M 104M 2025-03
Medtronic USD 2.7B 17M 2025-04
Merit Medical Systems USD 107.49M 4.91M 2025-03
Quest Diagnostics USD 476M 10M 2025-03
Smith & Nephew USD 1.35B 12.8M 2024-12
Stryker USD 2.3B 272M 2025-03
Tandem Diabetes Care USD 104.97M 871K 2025-03
Teleflex USD 222.71M 31.84M 2025-03
Terumo JPY 100.57B 4.22B 2025-03
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12



Baxter International مصاريف البيع والإدارة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.